financetom
Business
financetom
/
Business
/
Savara Starts Biologics License Application Submission for Lung Disease Treatment Candidate
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Savara Starts Biologics License Application Submission for Lung Disease Treatment Candidate
Dec 18, 2024 2:33 PM

05:07 PM EST, 12/18/2024 (MT Newswires) -- Savara (SVRA) said late Wednesday it started a rolling submission of a biologics license application, or BLA, to the US Food and Drug Administration for Molbreevi, aimed at potentially treating autoimmune Pulmonary Alveolar Proteinosis, a rare lung disease.

The clinical-stage biopharmaceutical company said it plans to finalize the BLA submission by the end of Q1 2025 and intends to seek priority review.

Shares of Savara were up 0.3% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wells Fargo Says 2015 OCC Agreements Terminated
Wells Fargo Says 2015 OCC Agreements Terminated
May 30, 2025
05:42 AM EDT, 05/30/2025 (MT Newswires) -- Wells Fargo ( WFC ) said late Thursday that the Office of the Comptroller of the Currency's 2015 agreements tied to the company's previously held financial units have terminated. This marks the 13th consent order closed by the lender's regulators since 2019 and the seventh since the start of the year, it said....
EU gains leverage in trade talks as US court casts doubt on tariffs, EU officials say
EU gains leverage in trade talks as US court casts doubt on tariffs, EU officials say
May 30, 2025
BRUSSELS (Reuters) - The European Union has gained leverage in trade talks with the United States after a U.S. court cast doubt on the legality of Washington's reciprocal tariffs, EU officials said on Friday. The European Commission said trade talks between Brussels and Washington would continue, with Europe sticking to its offer of mutual zero tariffs on industrial goods. There's...
Update: Gap Q1 Profit, Revenue Rise; Issues Outlook; Shares Fall Premarket
Update: Gap Q1 Profit, Revenue Rise; Issues Outlook; Shares Fall Premarket
May 30, 2025
05:42 AM EDT, 05/30/2025 (MT Newswires) -- (Updates to include more details on potential impact of tariffs and recent stock movement in the last two paragraphs.) Gap (GAP) reported late Thursday fiscal Q1 net income of $0.51 per diluted share, up from $0.41 a year earlier. Analysts polled by FactSet expected $0.44. Net Sales for the quarter ended May 3...
China's April shipments of foreign-branded mobile phones up 0.8% from prior year
China's April shipments of foreign-branded mobile phones up 0.8% from prior year
May 30, 2025
BEIJING, May 30 (Reuters) - China's shipments of foreign-branded mobile phones, including Apple Inc's ( AAPL ) iPhones, were up 0.8% year-on-year in April, according to data released by a government-affiliated research company on Friday. Calculations based on the data from the China Academy of Information and Communications Technology (CAICT) showed that April shipments of foreign-branded phones in China rose...
Copyright 2023-2025 - www.financetom.com All Rights Reserved